Article Details
Retrieved on: 2024-11-17 23:05:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses how GLP-1 receptor agonists, like semaglutide (Ozempic) and liraglutide, may benefit alcohol and substance use disorder management. Though Alzheimer's is briefly mentioned, the focus is not directly related.
Article found on: www.foxnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here